135 related articles for article (PubMed ID: 37132439)
21. CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling Pathway.
Chan S; Wang X; Wang Z; Du Y; Zuo X; Chen J; Sun R; Zhang Q; Lin L; Yang Y; Yu Z; Zhao H; Zhang H; Chen W
Int J Biol Sci; 2023; 19(7):2220-2233. PubMed ID: 37151875
[TBL] [Abstract][Full Text] [Related]
22. Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.
Alqurashi N; Hashimi SM; Alowaidi F; Ivanovski S; Wei MQ
Oncol Rep; 2018 Aug; 40(2):1083-1092. PubMed ID: 29845289
[TBL] [Abstract][Full Text] [Related]
23. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
24. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
25. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
[TBL] [Abstract][Full Text] [Related]
26. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
27. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
28. Proanthocyanidins inhibited colorectal cancer stem cell characteristics through Wnt/β-catenin signaling.
Chen Y; Yang Z; He X; Zhu W; Wang Y; Li J; Han Z; Wen J; Liu W; Yang Y; Zhang K
Environ Toxicol; 2023 Dec; 38(12):2894-2903. PubMed ID: 37551626
[TBL] [Abstract][Full Text] [Related]
29. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
30. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
[TBL] [Abstract][Full Text] [Related]
31. xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.
Tang B; Zhu J; Liu F; Ding J; Wang Y; Fang S; Zheng L; Qiu R; Chen M; Shu G; Xu M; Lu C; Zhao Z; Yang Y; Ji J
Cell Death Dis; 2022 Apr; 13(4):373. PubMed ID: 35440604
[TBL] [Abstract][Full Text] [Related]
32. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract][Full Text] [Related]
33. Polyphyllin II Induces Protective Autophagy and Apoptosis via Inhibiting PI3K/AKT/mTOR and STAT3 Signaling in Colorectal Cancer Cells.
Li JK; Sun HT; Jiang XL; Chen YF; Zhang Z; Wang Y; Chen WQ; Zhang Z; Sze SCW; Zhu PL; Yung KKL
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233191
[TBL] [Abstract][Full Text] [Related]
34. PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.
Chen J; Shao R; Li F; Monteiro M; Liu JP; Xu ZP; Gu W
Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1317-26. PubMed ID: 26399781
[TBL] [Abstract][Full Text] [Related]
35. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
Liu J
Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010
[TBL] [Abstract][Full Text] [Related]
36. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
[TBL] [Abstract][Full Text] [Related]
37. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
[TBL] [Abstract][Full Text] [Related]
38. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
Wei F; Zhang T; Yang Z; Wei JC; Shen HF; Xiao D; Wang Q; Yang P; Chen HC; Hu H; Chen ZP; Huang Q; Li WL; Cao J
Cell Physiol Biochem; 2018; 46(2):829-846. PubMed ID: 29627822
[TBL] [Abstract][Full Text] [Related]
39. MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39.
Liang Y; Zhu D; Hou L; Wang Y; Huang X; Zhou C; Zhu L; Wang Y; Li L; Gu Y; Luo M; Wang J; Meng X
Br J Cancer; 2020 Mar; 122(5):705-714. PubMed ID: 31919406
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
